Selected research
Industry Growth & Trends
Global Donepezil Hydrochloride Tablet Industry Growth and Trends Forecast to 2032
Market perspective
The global Donepezil Hydrochloride Tablet market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Donepezil Hydrochloride Tablet is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Donepezil Hydrochloride Tablet is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Donepezil Hydrochloride Tablet is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Donepezil Hydrochloride Tablet include Eisai, Luoxin Pharmaceutical, Pfizer, Huahai Pharmaceutical, Hansoh Pharma, Hisun Pharmaceutical, ARK PHA.LTD, Lupin and Globalstar, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Donepezil Hydrochloride Tablet market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Donepezil Hydrochloride Tablet market size, estimates, and forecasts are presented in terms of sales volume (K Pcs) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Donepezil Hydrochloride Tablet market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Donepezil Hydrochloride Tablet.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading manufacturers in the global Donepezil Hydrochloride Tablet market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Donepezil Hydrochloride Tablet Market by Company
Eisai
Luoxin Pharmaceutical
Pfizer
Huahai Pharmaceutical
Hansoh Pharma
Hisun Pharmaceutical
ARK PHA.LTD
Lupin
Globalstar
G Med Impex
Donepezil Hydrochloride Tablet Segment by Type
5 mg/tablet
10 mg/tablet
Donepezil Hydrochloride Tablet Segment by Application
Hospitals
Drugstores
Others
Donepezil Hydrochloride Tablet Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Donepezil Hydrochloride Tablet market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Donepezil Hydrochloride Tablet and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Donepezil Hydrochloride Tablet.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Donepezil Hydrochloride Tablet manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Donepezil Hydrochloride Tablet in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- 5 mg/tablet
- 10 mg/tablet
Applications
- Hospitals
- Drugstores
- Others
Companies covered
- Eisai
- Luoxin Pharmaceutical
- Pfizer
- Huahai Pharmaceutical
- Hansoh Pharma
- Hisun Pharmaceutical
- ARK PHA.LTD
- Lupin
- Globalstar
- G Med Impex
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Donepezil Hydrochloride Tablet Market Size Estimates and Forecasts (2021-2032)
- 1.2.2 Global Donepezil Hydrochloride Tablet Sales Estimates and Forecasts (2021-2032)
- 1.3 Donepezil Hydrochloride Tablet Market by Type
- 1.3.1 5 mg/tablet
- 1.3.2 10 mg/tablet
- 1.4 Global Donepezil Hydrochloride Tablet Market Size by Type
- 1.4.1 Global Donepezil Hydrochloride Tablet Market Size Overview by Type (2021-2032)
- 1.4.2 Global Donepezil Hydrochloride Tablet Historic Market Size Review by Type (2021-2026)
- 1.4.3 Global Donepezil Hydrochloride Tablet Forecasted Market Size by Type (2027-2032)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America Donepezil Hydrochloride Tablet Sales Breakdown by Type (2021-2026)
- 1.5.2 Europe Donepezil Hydrochloride Tablet Sales Breakdown by Type (2021-2026)
- 1.5.3 Asia-Pacific Donepezil Hydrochloride Tablet Sales Breakdown by Type (2021-2026)
- 1.5.4 South America Donepezil Hydrochloride Tablet Sales Breakdown by Type (2021-2026)
- 1.5.5 Middle East and Africa Donepezil Hydrochloride Tablet Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
- 2.1 Donepezil Hydrochloride Tablet Industry Trends
- 2.2 Donepezil Hydrochloride Tablet Industry Drivers
- 2.3 Donepezil Hydrochloride Tablet Industry Opportunities and Challenges
- 2.4 Donepezil Hydrochloride Tablet Industry Restraints
3 Market Competitive Landscape by Company
- 3.1 Global Top Players by Donepezil Hydrochloride Tablet Revenue (2021-2026)
- 3.2 Global Top Players by Donepezil Hydrochloride Tablet Sales (2021-2026)
- 3.3 Global Top Players by Donepezil Hydrochloride Tablet Price (2021-2026)
- 3.4 Global Donepezil Hydrochloride Tablet Industry Company Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Donepezil Hydrochloride Tablet Major Company Production Sites & Headquarters
- 3.6 Global Donepezil Hydrochloride Tablet Company, Product Type & Application
- 3.7 Global Donepezil Hydrochloride Tablet Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Donepezil Hydrochloride Tablet Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Donepezil Hydrochloride Tablet Players Market Share by Revenue in 2025
- 3.8.3 2025 Donepezil Hydrochloride Tablet Tier 1, Tier 2, and Tier 3
4 Donepezil Hydrochloride Tablet Regional Status and Outlook
- 4.1 Global Donepezil Hydrochloride Tablet Market Size and CAGR by Region: 2021 VS 2025 VS 2032
- 4.2 Global Donepezil Hydrochloride Tablet Historic Market Size by Region
- 4.2.1 Global Donepezil Hydrochloride Tablet Sales in Volume by Region (2021-2026)
- 4.2.2 Global Donepezil Hydrochloride Tablet Sales in Value by Region (2021-2026)
- 4.2.3 Global Donepezil Hydrochloride Tablet Sales (Volume & Value), Price and Gross Margin (2021-2026)
- 4.3 Global Donepezil Hydrochloride Tablet Forecasted Market Size by Region
- 4.3.1 Global Donepezil Hydrochloride Tablet Sales in Volume by Region (2027-2032)
- 4.3.2 Global Donepezil Hydrochloride Tablet Sales in Value by Region (2027-2032)
- 4.3.3 Global Donepezil Hydrochloride Tablet Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Donepezil Hydrochloride Tablet by Application
- 5.1 Donepezil Hydrochloride Tablet Market by Application
- 5.1.1 Hospitals
- 5.1.2 Drugstores
- 5.1.3 Others
- 5.2 Global Donepezil Hydrochloride Tablet Market Size by Application
- 5.2.1 Global Donepezil Hydrochloride Tablet Market Size Overview by Application (2021-2032)
- 5.2.2 Global Donepezil Hydrochloride Tablet Historic Market Size Review by Application (2021-2026)
- 5.2.3 Global Donepezil Hydrochloride Tablet Forecasted Market Size by Application (2027-2032)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America Donepezil Hydrochloride Tablet Sales Breakdown by Application (2021-2026)
- 5.3.2 Europe Donepezil Hydrochloride Tablet Sales Breakdown by Application (2021-2026)
- 5.3.3 Asia-Pacific Donepezil Hydrochloride Tablet Sales Breakdown by Application (2021-2026)
- 5.3.4 South America Donepezil Hydrochloride Tablet Sales Breakdown by Application (2021-2026)
- 5.3.5 Middle East and Africa Donepezil Hydrochloride Tablet Sales Breakdown by Application (2021-2026)
6 Company Profiles
- 6.1 Eisai
- 6.1.1 Eisai Company Information
- 6.1.2 Eisai Business Overview
- 6.1.3 Eisai Donepezil Hydrochloride Tablet Sales, Revenue and Gross Margin (2021-2026)
- 6.1.4 Eisai Donepezil Hydrochloride Tablet Product Portfolio
- 6.1.5 Eisai Recent Developments
- 6.2 Luoxin Pharmaceutical
- 6.2.1 Luoxin Pharmaceutical Company Information
- 6.2.2 Luoxin Pharmaceutical Business Overview
- 6.2.3 Luoxin Pharmaceutical Donepezil Hydrochloride Tablet Sales, Revenue and Gross Margin (2021-2026)
- 6.2.4 Luoxin Pharmaceutical Donepezil Hydrochloride Tablet Product Portfolio
- 6.2.5 Luoxin Pharmaceutical Recent Developments
- 6.3 Pfizer
- 6.3.1 Pfizer Company Information
- 6.3.2 Pfizer Business Overview
- 6.3.3 Pfizer Donepezil Hydrochloride Tablet Sales, Revenue and Gross Margin (2021-2026)
- 6.3.4 Pfizer Donepezil Hydrochloride Tablet Product Portfolio
- 6.3.5 Pfizer Recent Developments
- 6.4 Huahai Pharmaceutical
- 6.4.1 Huahai Pharmaceutical Company Information
- 6.4.2 Huahai Pharmaceutical Business Overview
- 6.4.3 Huahai Pharmaceutical Donepezil Hydrochloride Tablet Sales, Revenue and Gross Margin (2021-2026)
- 6.4.4 Huahai Pharmaceutical Donepezil Hydrochloride Tablet Product Portfolio
- 6.4.5 Huahai Pharmaceutical Recent Developments
- 6.5 Hansoh Pharma
- 6.5.1 Hansoh Pharma Company Information
- 6.5.2 Hansoh Pharma Business Overview
- 6.5.3 Hansoh Pharma Donepezil Hydrochloride Tablet Sales, Revenue and Gross Margin (2021-2026)
- 6.5.4 Hansoh Pharma Donepezil Hydrochloride Tablet Product Portfolio
- 6.5.5 Hansoh Pharma Recent Developments
- 6.6 Hisun Pharmaceutical
- 6.6.1 Hisun Pharmaceutical Company Information
- 6.6.2 Hisun Pharmaceutical Business Overview
- 6.6.3 Hisun Pharmaceutical Donepezil Hydrochloride Tablet Sales, Revenue and Gross Margin (2021-2026)
- 6.6.4 Hisun Pharmaceutical Donepezil Hydrochloride Tablet Product Portfolio
- 6.6.5 Hisun Pharmaceutical Recent Developments
- 6.7 ARK PHA.LTD
- 6.7.1 ARK PHA.LTD Company Information
- 6.7.2 ARK PHA.LTD Business Overview
- 6.7.3 ARK PHA.LTD Donepezil Hydrochloride Tablet Sales, Revenue and Gross Margin (2021-2026)
- 6.7.4 ARK PHA.LTD Donepezil Hydrochloride Tablet Product Portfolio
- 6.7.5 ARK PHA.LTD Recent Developments
- 6.8 Lupin
- 6.8.1 Lupin Company Information
- 6.8.2 Lupin Business Overview
- 6.8.3 Lupin Donepezil Hydrochloride Tablet Sales, Revenue and Gross Margin (2021-2026)
- 6.8.4 Lupin Donepezil Hydrochloride Tablet Product Portfolio
- 6.8.5 Lupin Recent Developments
- 6.9 Globalstar
- 6.9.1 Globalstar Company Information
- 6.9.2 Globalstar Business Overview
- 6.9.3 Globalstar Donepezil Hydrochloride Tablet Sales, Revenue and Gross Margin (2021-2026)
- 6.9.4 Globalstar Donepezil Hydrochloride Tablet Product Portfolio
- 6.9.5 Globalstar Recent Developments
- 6.10 G Med Impex
- 6.10.1 G Med Impex Company Information
- 6.10.2 G Med Impex Business Overview
- 6.10.3 G Med Impex Donepezil Hydrochloride Tablet Sales, Revenue and Gross Margin (2021-2026)
- 6.10.4 G Med Impex Donepezil Hydrochloride Tablet Product Portfolio
- 6.10.5 G Med Impex Recent Developments
7 North America by Country
- 7.1 North America Donepezil Hydrochloride Tablet Sales by Country
- 7.1.1 North America Donepezil Hydrochloride Tablet Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.1.2 North America Donepezil Hydrochloride Tablet Sales by Country (2021-2026)
- 7.1.3 North America Donepezil Hydrochloride Tablet Sales Forecast by Country (2027-2032)
- 7.2 North America Donepezil Hydrochloride Tablet Market Size by Country
- 7.2.1 North America Donepezil Hydrochloride Tablet Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2.2 North America Donepezil Hydrochloride Tablet Market Size by Country (2021-2026)
- 7.2.3 North America Donepezil Hydrochloride Tablet Market Size Forecast by Country (2027-2032)
8 Europe by Country
- 8.1 Europe Donepezil Hydrochloride Tablet Sales by Country
- 8.1.1 Europe Donepezil Hydrochloride Tablet Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.1.2 Europe Donepezil Hydrochloride Tablet Sales by Country (2021-2026)
- 8.1.3 Europe Donepezil Hydrochloride Tablet Sales Forecast by Country (2027-2032)
- 8.2 Europe Donepezil Hydrochloride Tablet Market Size by Country
- 8.2.1 Europe Donepezil Hydrochloride Tablet Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2.2 Europe Donepezil Hydrochloride Tablet Market Size by Country (2021-2026)
- 8.2.3 Europe Donepezil Hydrochloride Tablet Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
- 9.1 Asia-Pacific Donepezil Hydrochloride Tablet Sales by Country
- 9.1.1 Asia-Pacific Donepezil Hydrochloride Tablet Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.1.2 Asia-Pacific Donepezil Hydrochloride Tablet Sales by Country (2021-2026)
- 9.1.3 Asia-Pacific Donepezil Hydrochloride Tablet Sales Forecast by Country (2027-2032)
- 9.2 Asia-Pacific Donepezil Hydrochloride Tablet Market Size by Country
- 9.2.1 Asia-Pacific Donepezil Hydrochloride Tablet Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2.2 Asia-Pacific Donepezil Hydrochloride Tablet Market Size by Country (2021-2026)
- 9.2.3 Asia-Pacific Donepezil Hydrochloride Tablet Market Size Forecast by Country (2027-2032)
10 South America by Country
- 10.1 South America Donepezil Hydrochloride Tablet Sales by Country
- 10.1.1 South America Donepezil Hydrochloride Tablet Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.1.2 South America Donepezil Hydrochloride Tablet Sales by Country (2021-2026)
- 10.1.3 South America Donepezil Hydrochloride Tablet Sales Forecast by Country (2027-2032)
- 10.2 South America Donepezil Hydrochloride Tablet Market Size by Country
- 10.2.1 South America Donepezil Hydrochloride Tablet Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2.2 South America Donepezil Hydrochloride Tablet Market Size by Country (2021-2026)
- 10.2.3 South America Donepezil Hydrochloride Tablet Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
- 11.1 Middle East and Africa Donepezil Hydrochloride Tablet Sales by Country
- 11.1.1 Middle East and Africa Donepezil Hydrochloride Tablet Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.1.2 Middle East and Africa Donepezil Hydrochloride Tablet Sales by Country (2021-2026)
- 11.1.3 Middle East and Africa Donepezil Hydrochloride Tablet Sales Forecast by Country (2027-2032)
- 11.2 Middle East and Africa Donepezil Hydrochloride Tablet Market Size by Country
- 11.2.1 Middle East and Africa Donepezil Hydrochloride Tablet Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2.2 Middle East and Africa Donepezil Hydrochloride Tablet Market Size by Country (2021-2026)
- 11.2.3 Middle East and Africa Donepezil Hydrochloride Tablet Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
- 12.1 Donepezil Hydrochloride Tablet Value Chain Analysis
- 12.1.1 Donepezil Hydrochloride Tablet Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 Donepezil Hydrochloride Tablet Production Mode & Process
- 12.2 Donepezil Hydrochloride Tablet Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 Donepezil Hydrochloride Tablet Distributors
- 12.2.3 Donepezil Hydrochloride Tablet Customers
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst